Drugs of Abuse Testing Market Analysis: Size, Share, Growth, and Forecast Trends 2030
In an era where the illicit consumption of drugs poses significant challenges to workplace safety and public health, the drugs of abuse testing market is witnessing remarkable growth. Developed economies are increasingly turning to drugs of abuse testing for various purposes, including pre-employment screening, random drug/alcohol testing, post-incident screening, and abstinence monitoring. The need to address the consequences of illicit drug addiction, such as reduced productivity, job instability, and workplace accidents, has driven private and public employers to prioritize drug abstinence through periodic testing.
The drugs of abuse testing market is expected to experience substantial growth due to the rising demand for drug abuse treatments, stringent regulations on alcohol and drug testing, increasing drug-related mortality rates, and government initiatives aimed at tackling this issue. Notably, the commercial landscape of drugs of abuse testing has evolved to keep up with emerging substances of abuse. Moreover, the applications of drugs of abuse testing kits have expanded beyond the workplace to include sports, checkpoints, and random screenings, presenting lucrative opportunities for market participants.
Tectonic Shift: From Laboratory Screening to On-the-Spot Testing
One significant shift in the market is the move from lab-based testing to on-the-spot screening, driven by cost-effectiveness and rapid results delivery. Law enforcement agencies, in particular, prefer the use of rapid on-the-spot screening tests. Manufacturers have responded by introducing innovative and user-friendly disposable products at competitive prices to meet the growing demand.
Urine Testing Dominates the Market
The urine segment accounted for the highest revenue in 2019 and is expected to maintain its dominant position throughout the forecast period. This is primarily attributed to the affordability of urine sample analysis kits and the widespread availability of point-of-care tests. Urine as a specimen for drug testing offers an extended window of detection, making it a preferred choice.
Rising Drug Addiction Rates Drive Market Growth
The growing number of individuals consuming alcohol and illicit drugs, including cocaine, is a significant driver for the drugs of abuse testing market. Other factors fueling market growth include increased institutional use of drug testing, the proliferation of illicit drug consumption and trade, a rise in road accidents, and higher mortality rates. According to the National Institute of Drug Abuse (NIDA), approximately 52 million people use prescription drugs for nonmedical reasons. Technological advancements in drug screening devices and stringent government regulations mandating drug screening will further boost market performance.
Challenges and Threats to Market Growth
Despite the presence of technologically advanced products, the drugs of abuse testing market faces challenges, such as the inability to detect low-dose designer drugs, which hampers short-term growth. Additionally, the social stigma associated with drug abuse testing and debates around drug legalization pose direct threats to the market’s steady growth. In certain countries, there is a lack of awareness regarding drug testing as a potential breach of fundamental privacy rights, which further restricts market expansion.
Market Dynamics in Developing and Low-Income Regions
North America leads the global market, thanks to government initiatives and a stringent legal framework. In the United States, authorities have mandated drug abuse testing in critical industry sectors such as defense, oil and gas, mining, and transportation.
In contrast, developing countries in Latin America and Africa struggle with low awareness and inadequate social support, leading to increased illicit drug consumption. The World Health Organization (WHO) reports that 77% of Brazilian children regularly consume alcohol. Aggressive marketing of tobacco and alcohol in low-income countries exacerbates the issue. Unfortunately, legal systems in these regions are often ineffective at curbing these malpractices, resulting in sluggish growth for the drugs of abuse testing market.
The drugs of abuse testing market is highly competitive, with multiple players vying for market share. Regional players dominate in their respective geographies. Prominent companies operating in the market include One Step Detect Associates, Abbott Diagnostics, Accutech, Acon Laboratories Inc., Agilent Technologies, Alfa Scientific, American Bio Medica, Beckman Coulter, Biophor Diagnostics, Bio-Rad Laboratories, Bioscan Screening Systems, Confirm Biosciences, Danaher Corp., Devon Medical Products, Elitech Group, Express Diagnostics International Inc., Hoffmann-La Roche, Ltd., Identa Corp., Lifeloc Technologies, Lifesign, Mavand Solutions, Medtest Dx, Medtox Diagnostics, and Mossman Associates.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/drugs-of-abuse-testing-market
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad